Stem Cell Factor/c-kit Receptor Signaling Enhances the Proliferation and Invasion of Colorectal Cancer Cells Through the PI3K/Akt Pathway

被引:0
|
作者
Akira Yasuda
Hirozumi Sawai
Hiroki Takahashi
Nobuo Ochi
Yoichi Matsuo
Hitoshi Funahashi
Mikinori Sato
Yuji Okada
Hiromitsu Takeyama
Tadao Manabe
机构
[1] Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterological Surgery
来源
关键词
c-; SCF; Colorectal cancer; PI3K/Akt; Proliferation; Invasion;
D O I
暂无
中图分类号
学科分类号
摘要
In this study, we examined the role of c-kit receptor (KIT) signal transduction on the proliferation and invasion of colorectal cancer cells. We found that c-kit was expressed in 2 colorectal cancer cell lines as determined by RT-PCR, Western blot, and flow cytometry. In KIT-positive lines, KIT was activated by stem cell factor (SCF). SCF enhanced cellular proliferation of positive lines as demonstrated by the WST-1 proliferation assay. Furthermore, SCF enhanced the invasive ability of KIT-positive cell lines. SCF stimulation upregulated p44/42 mitogen-activated protein kinase (MAPK) and Akt as shown by Western blot. We examined the roles played by p44/42 MAPK and phosphatidylinositol 3-kinase (PI3K)/Akt pathways in proliferation and invasion. PI3K/Akt activity strongly correlated with proliferation and invasion and p44/42 MAPK was correlated with only invasion. In conclusion, the SCF-enhanced proliferation and invasion of KIT-positive colorectal cancer cells is achieved mainly through the PI3K/Akt pathway.
引用
收藏
页码:2292 / 2300
页数:8
相关论文
共 50 条
  • [41] Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway
    Lin, Lin
    Gao, Yunan
    Hu, Xiaochen
    Ouyang, Jiabao
    Liu, Chunbo
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [42] Effects of Atractylon on Proliferation and Apoptosis of Intestinal Cancer Cells Through PI3K/AKT/mTOR Signaling Pathway
    Mao, Junjun
    Wang, Xinping
    Yu, Minghui
    Sun, Chenkun
    CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (05) : 153 - 160
  • [43] Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway
    Lin Lin
    Yunan Gao
    Xiaochen Hu
    Jiabao Ouyang
    Chunbo Liu
    BMC Women's Health, 22
  • [44] Regulator of G protein signaling 4 inhibits human melanoma cells proliferation and invasion through the PI3K/AKT signaling pathway
    Xue, Xiaotong
    Wang, Lihua
    Meng, Xianguang
    Jiao, Jing
    Dang, Ningning
    ONCOTARGET, 2017, 8 (45) : 78530 - 78544
  • [45] RACGAP1 promotes lung cancer cell proliferation through the PI3K/AKT signaling pathway
    Xu, Zhiyang
    Wu, Shaohang
    Tu, Jiahua
    Wang, Mingyang
    Liang, Weicheng
    Cheng, Jiangdong
    Guan, Jun
    Xu, Jianxin
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [46] Rapamycin inhibits proliferation and apoptosis of retinoblastoma cells through PI3K/AKT signaling pathway
    Yao, Jun
    Xu, Min
    Liu, Ziyao
    ONCOLOGY LETTERS, 2020, 19 (04) : 2950 - 2956
  • [47] HRK inhibits colorectal cancer cells proliferation by suppressing the PI3K/AKT/mTOR pathway
    Wang, Haowei
    Chen, Yujia
    Yuan, Qinzi
    Chen, Lixia
    Dai, Peiling
    Li, Xuenong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] ICAM-3-induced cancer cell proliferation through the PI3K/Akt pathway
    Kim, Yong Geon
    Kim, Mi Jin
    Lim, Jong-Seok
    Lee, Myeong-Sok
    Kim, Jun Suk
    Yoo, Young Do
    CANCER LETTERS, 2006, 239 (01) : 103 - 110
  • [49] CHRNA7 inhibits cell invasion and metastasis of LoVo human colorectal cancer cells through PI3K/Akt signaling
    Xiang, Tao
    Yu, Feng
    Fei, Rushan
    Qian, Jing
    Chen, Wenbin
    ONCOLOGY REPORTS, 2016, 35 (02) : 999 - 1005
  • [50] Asiatic Acid Interferes with Invasion and Proliferation of Breast Cancer Cells by Inhibiting WAVE3 Activation through PI3K/AKT Signaling Pathway
    Gou, Xiao-jun
    Bai, Huan-huan
    Liu, Li-wei
    Chen, Hong-yu
    Shi, Qi
    Chang, Li-sheng
    Ding, Ming-ming
    Shi, Qin
    Zhou, Mei-xiang
    Chen, Wen-li
    Zhang, Li-min
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020